THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Patent Owner
Stats
- 1,377 US PATENTS IN FORCE
- 142 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 1,377 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 70,112 Total Citation Count
- Dec 08, 1977 Earliest Filing
- 904 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,233 COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISEASESNov 21, 17Mar 15, 18[A61K]
2018/0057,603 Combination of IFN-gamma with Anti-ERBB Antibody for the Treatment of CancersFeb 09, 16Mar 01, 18[A61K, C07K]
2018/0057,609 Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific AntibodyAug 30, 17Mar 01, 18[A61K, C07K]
2018/0057,841 METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOROct 27, 17Mar 01, 18[A61K, C12N, C07K]
2018/0051,243 SYSTEM, METHOD, AND DEVICE FOR HIGH-THROUGHPUT, AUTOMATED CULTURING OF GENETICALLY MODIFIED ORGANISMSMar 11, 16Feb 22, 18[C12M]
2017/0360,913 COMPOSITIONS AND METHODS FOR T CELL DELIVERY OF THERAPEUTIC MOLECULESOct 30, 15Dec 21, 17[A61K, C12N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9919038 Compositions comprising angiogenic factors and methods of use thereofJan 15, 16Mar 20, 18[A61K, C12N, C07K]
9920295 Bioreactor for isolation of rare cells and methods of useFeb 21, 13Mar 20, 18[A61K, C12Q, C12N, C12M, G01N]
9913885 Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the sameJul 11, 16Mar 13, 18[A61K, C12N, C07K]
9914535 Passive rotor control mechanism for micro air vehiclesMar 14, 14Mar 13, 18[H02P, G01C, B64C]
9895351 Indomethacin analogs for the treatment of castrate-resistant prostate cancerApr 19, 16Feb 20, 18[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0119,769 SCAFFOLDS FOR INHIBITORS OF MENIN-MLL INTERACTIONSAbandonedJun 10, 15May 04, 17[A61K, G01N]
2017/0056,524 COMPOSITIONS AND METHODS FOR TARGETED EPIGENETIC MODIFICATIONAbandonedSep 09, 16Mar 02, 17[A61K]
2017/0014,501 METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASEAbandonedFeb 16, 16Jan 19, 17[A61K]
2016/0362,478 CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIESAbandonedFeb 10, 15Dec 15, 16[A61K, C07K]
2016/0287,726 CATIONIC CONTRAST AGENTS AND METHODS OF USING THE SAMEAbandonedMar 21, 16Oct 06, 16[A61K]
2016/0289,334 Compositions and Methods of Treating TumorsAbandonedJun 03, 15Oct 06, 16[A61K, A61N, C07K]
2016/0167,331 IMPROVED REVERSIBLE ADHESIVES AND METHODS OF FORMING THE SAMEAbandonedAug 01, 14Jun 16, 16[B29C, B32B]
2016/0168,099 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USEAbandonedAug 13, 15Jun 16, 16[A61K, C07D]
2016/0151,461 Cardio-Metabolic and Vascular Effects of GLP-1 MetabolitesAbandonedMar 14, 14Jun 02, 16[A61K]
2016/0084,820 METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITISAbandonedSep 16, 14Mar 24, 16[G01N]
2016/0032,316 Purification and Purity Assessment of RNA Molecules Synthesized with Modified NucleosidesAbandonedMar 13, 14Feb 04, 16[C07H, C12P, C12N, C07K]
2016/0017,286 IKAROS INHIBITION TO AUGMENT ADOPTIVE T CELL TRANSFERAbandonedMar 06, 14Jan 21, 16[A61K, C12N]
2016/0002,655 PHARMACEUTICAL PROTEINS, HUMAN THERAPEUTICS, HUMAN SERUM ALBUMIN INSULIN, NATIVE CHOLERA TOXIN B SUBUNIT ON TRANSGENIC PLASTIDSAbandonedJul 27, 15Jan 07, 16[C12N, A01H, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.